WHO WPRO Regional Polio Reference Laboratory, National Health Commission Key Laboratory for Biosafety, National Health Commission Key Laboratory for Medical Virology, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, 155 Changbai Road, Beijing 102206, China.
Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan 430071, China.
Viruses. 2023 Feb 12;15(2):511. doi: 10.3390/v15020511.
Coxsackievirus A6 (CVA6), a member of species A enterovirus, is associated with outbreaks of hand-foot-and-mouth disease and causes a large nationwide burden of disease. However, the molecular pathogenesis of CVA6 remains unclear. In the present study, we established a suckling Institute of Cancer Research (ICR) mouse infection model to explore the neural pathogenicity of CVA6. Five-day-old mice infected with CVA6 strain F219 showed lethargy and paralysis, and died 5 or 6 days after infection via IM injection. Cerebral edema and neuronal cell swelling were observed in the infected brain tissue, and we found that the CVA6 VP1 antigen could co-localize with GFAP-positive astrocytes in infected mouse brain using an immunofluorescence assay. CVA6 strain F219 can also infect human glioma (U251) cells. Transcriptome analysis of brain tissues from infected mice and infected U251 cells showed that significantly differentially expressed genes were enriched in antiviral and immune response and neurological system processes. These results indicate that CVA6 could cause neural pathogenesis and provide basic data for exploring the mechanism of how host-cell interactions affect viral replication and pathogenesis. Importance: Coxsackievirus A6 (CVA6) surpasses the two main pathogens, enterovirus 71 (EV-A71) and coxsackievirus A16 (CVA16), which are the leading pathogens causing HFMD in many provinces of China. In our study, CVA6 infection caused neurogenic pathogenesis in a neonatal murine model, manifesting as cerebral edema and neuronal cell swelling, CVA6 VP1 antigen could co-localize with GFAP-positive astrocytes in the infected mouse brain. Based on CVA6-infected brain tissue and U251 cell transcriptome analysis, we found upregulated antiviral and immune response-related genes such as Zbp1, Usp18, Oas2, Irf7, Ddx60, Ifit3, Ddx58, and Isg15, while the neurological system process-related genes were downregulated, including Fcrls, Ebnrb, Cdk1, and Anxa5.
柯萨奇病毒 A6(CVA6)是 A 组肠道病毒的一个成员,与手足口病的爆发有关,并导致了很大的全国性疾病负担。然而,CVA6 的分子发病机制尚不清楚。在本研究中,我们建立了一个乳鼠感染模型来探索 CVA6 的神经致病性。用 CVA6 株 F219 感染 5 日龄乳鼠后,感染鼠出现昏睡和瘫痪,通过肌内注射感染后 5 或 6 天死亡。感染脑组织中观察到脑水肿和神经元细胞肿胀,通过免疫荧光检测发现 CVA6 VP1 抗原可与感染鼠脑内的 GFAP 阳性星形胶质细胞共定位。CVA6 株 F219 也可感染人神经胶质瘤(U251)细胞。感染鼠脑组织和感染 U251 细胞的转录组分析表明,显著差异表达基因富集于抗病毒和免疫反应以及神经系统过程。这些结果表明 CVA6 可引起神经发病机制,并为探索宿主细胞相互作用如何影响病毒复制和发病机制提供了基础数据。
柯萨奇病毒 A6(CVA6)在中国许多省份已超过手足口病的两个主要病原体,肠道病毒 71 型(EV-A71)和柯萨奇病毒 A16 型(CVA16),成为导致手足口病的主要病原体。在我们的研究中,CVA6 感染导致新生鼠模型发生神经原性发病机制,表现为脑水肿和神经元细胞肿胀,CVA6 VP1 抗原可与感染鼠脑内的 GFAP 阳性星形胶质细胞共定位。基于 CVA6 感染脑组织和 U251 细胞转录组分析,我们发现上调了抗病毒和免疫反应相关基因,如 Zbp1、Usp18、Oas2、Irf7、Ddx60、Ifit3、Ddx58 和 Isg15,而神经系统过程相关基因下调,包括 Fcrls、Ebnrb、Cdk1 和 Anxa5。